FDA OKs emergency use of LabCorp RNA extraction method for coronavirus test

The FDA has signed off on emergency use of LabCorp's (NYSE:LH) high-throughput method using heat and technology to extract RNA from swab samples for SARS-CoV-2 molecular testing. The company says the heat extraction process, which eliminates the need for RNA extraction reagents, improves the speed and efficiency of real-time polymerase chain reaction (RT-PCR) tests.

https://seekingalpha.com/news/3619319-fda-oks-emergency-use-of-labcorp-rna-extraction-method-for-coronavirus-testing